VAERS data released Friday by the Centers for Disease Control and Prevention included a total of 1,088,560 reports of adverse events from all age groups following COVID vaccines, including 23,149 deaths and 183,311 serious injuries between Dec. 14, 2020, and Jan. 28, 2022.
The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,088,560 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Jan. 28, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 23,149 reports of deaths — an increase of 542 over the previous week — and 183,311 reports of serious injuries, including deaths, during the same time period — up 4,317 compared with the previous week.
Excluding “foreign reports” to VAERS, 747,760 adverse events, including 10,527 deaths and 69,089 serious injuries, were reported in the U.S. between Dec. 14, 2020, and Jan. 28, 2022.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 10,527 U.S. deaths reported as of Jan. 28, 19% occurred within 24 hours of vaccination, 23% occurred within 48 hours of vaccination and 60% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 536.8 million COVID vaccine doses had been administered as of Jan. 28, including 315 million doses of Pfizer, 204 million doses of Moderna and 18 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to Jan. 28, 2022, for 5- to 11-year-olds show:
The most recent death involves a 7-year-old girl (VAERS I.D. 1975356) from Minnesota who died 11 days after receiving her first dose of Pfizer’s COVID vaccine when she was found unresponsive by her mother. An autopsy is pending.
- 14 reports of myocarditis and pericarditis (heart inflammation).
- 26 reports of blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to Jan. 28, 2022, for 12- to 17-year-olds show:
The most recent deaths involve a 13-year-old male (VAERS I.D. 2042005) from an unidentified state who died from a sudden heart attack seven months after receiving his second dose of Moderna, and a 17-year-old female from an unidentified state (VAERS I.D. 2039111) who died after receiving her first dose of Moderna. Medical information was limited and it is unknown if an autopsy was performed in either case.
- 68 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases
attributed to Pfizer’s vaccine. - 615 reports of myocarditis and pericarditis with 603 cases attributed to Pfizer’s vaccine.
- 155 reports of blood clotting disorders, with all cases attributed to Pfizer.
U.S. VAERS data from Dec. 14, 2020, to Jan. 28, 2022, for all age groups combined, show:
- 19% of deaths were related to cardiac disorders.
- 54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
- The average age of death was 72.3.
- As of Jan. 28, 4,992 pregnant women reported adverse events related to COVID vaccines, including 1,597reports of miscarriage or premature birth.
- Of the 3,509 cases of Bell’s Palsy reported, 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.
- 850 reports of Guillain-Barré syndrome (GBS), with 41% of cases attributed to Pfizer, 30% to Moderna and 28% to J&J.
- 2,300 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 1,560 reports of myocardial infarction.
- 12,864 reports of blood clotting disorders in the U.S. Of those, 5,730 reports were attributed to Pfizer, 4,580 reports to Moderna and 2,506 reports to J&J.
- 3,878 cases of myocarditis and pericarditis with 2,387 cases attributed to Pfizer, 1,313 cases to Moderna and 166 cases to J&J’s COVID vaccine.
CDC advisory panel votes unanimously to recommend Moderna ‘Spikevax’ vaccine for 18 and older…
Continue reading the full story [icon name=”arrow-right” prefix=”fas”] CDC Panel Backs Moderna ‘Spikevax’ for 18 and Older, as COVID Vaccine Injuries Continue to Rise, VAERS Data Show • Children’s Health Defense